Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia
Open Access
- 23 April 2007
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 40 (1) , 13-18
- https://doi.org/10.1038/sj.bmt.1705669
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimenBritish Journal of Haematology, 2006
- Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemiaBone Marrow Transplantation, 2006
- Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: The Mexican experienceAmerican Journal of Hematology, 2006
- Alemtuzumab, Fludarabine and Melphalan as a Conditioning Therapy in Severe Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome—Single Center ExperienceJapanese Journal of Clinical Oncology, 2006
- Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemiaBone Marrow Transplantation, 2005
- Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemiaTransplantation and Cellular Therapy, 2004
- CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic TransplantationBone Marrow Transplantation, 2002
- Allogeneic bone marrow transplantation in the developing world: experience from a center in IndiaBone Marrow Transplantation, 2001
- High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimenBone Marrow Transplantation, 1999
- Marrow Transplantation for Treatment of Aplastic AnemiaNew England Journal of Medicine, 1977